Use of targeted anticytokine treatments in heart failure.
Mohler
K M
KM
Murray
K M
KM
Mann
D L
DL
Francis
G
G
D015703:Antigens, CD / Q000627:therapeutic use; D000068800:Etanercept; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000737:chemistry / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000737:chemistry / Q000627:therapeutic use*; D047889:Receptors, Tumor Necrosis Factor, Type II; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D015703:Antigens, CD; D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D047889:Receptors, Tumor Necrosis Factor, Type II; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept